Transform TB Treatment with VDOT

Maximize Patient Support and Improve Public Health Outcomes with SureAdhere's Virtual Care Platform

SureAdhere Cover

Understanding the Challenges

The World Health Organization recommends Directly Observed Therapy (DOT) as the standard treatment for TB, and it has been widely adopted globally. However, DOT places immense pressure on Nurses and TB clinics, which can compromise the success of TB management programs and lead to resource constraints and burnout. Consequently, the effectiveness of tuberculosis care is often compromised, further exacerbating the burden on healthcare systems. 

Common challenges associated with TB Treatment:

  • Cost and inefficiency: The traditional DOT approach is costly and inefficient, requiring significant resources across multiple areas.
  • Manual processes: Involves extensive paperwork and maintenance of multiple systems for patient record management.
  • Increased workload: Increased operational costs and added workload for nurses and healthcare workers.

The Digital Solution for Effective VDOT

digital solution for effective tb treatment

SureAdhere tackles these challenges by providing a comprehensive virtual care solution for TB care providers and clinics. Our platform enables Video Directly Observed Therapy (VDOT) and offers personalized, timely remote treatment support for patients. Giving patients more autonomy and privacy, we also help TB care providers foster long-term treatment adherence and satisfaction, leading to more effective TB programs.

SureAdhere empowers nurses to eliminate routine in-person patient visits, help clinics centralize and streamline DOT administration, and reduce the costs of current DOT programs.

Pill

Drug-by-drug Medication Support

Create comprehensive treatment records at every dose by combining dosing histories, task lists, action logging, and side-effect tracking

Virtual care

Virtual Engagement Capabilities

Seamlessly engage participants in real-time by combining SMS and secure in-app messaging with integrated live virtual visits

Scalability

Scaled Program Capacity

Optimize staff resources by focusing on high-need patients, while increasing observed medication doses and reducing admin costs and manual record-keeping

interoperable

Interoperable

Integrate seamlessly with EHRs and EMRs to enable centralized data capture, streamline workflows & enhance patient record monitoring

Why SureAdhere?

SureAdhere by Dimagi works with over 350 healthcare & clinical programs across the world and is US HIPAA and European GDPR compliant. Additionally, the platform meets the 21 CFR-Part 11 compliance requirements.

  • High Treatment Success Rate
    SureAdhere ensures a high treatment success rate among patients, which directly contributes to the overall success of TB programs. Our platform facilitates effective and efficient treatment delivery while adhering to the US Center for Disease Control & Prevention (CDC) and WHO guidelines through recommended VDOT 
  • Resource Optimization and Cost Savings
    By eliminating the need for travel related to in-person DOT, SureAdhere optimizes limited healthcare resources and saves valuable time. This ensures that clinics operate efficiently without unnecessary expenditures, allowing healthcare providers to focus their efforts and resources on patient care rather than logistics.

  • Streamlined Operations
    SureAdhere simplifies daily tasks, reducing the time and effort required for treatment management. This leads to higher nurse satisfaction and contributes to better overall TB program outcomes, making the entire treatment process more manageable and effective.
  • Improved Patient Convenience
    Provide patients with greater autonomy and privacy, along with support to help them adhere to their treatment, leading to better program outcomes.

Backed by Evidence

SureAdhere’s reliability is proven through rigorous studies and real-world application, ensuring that patients receive the highest standard of care.

NIH 1
Randomized Non-inferiority trial found electronic DOT non-inferior to in-person DOT for TB  treatment, supporting its efficacy as a viable digital alternative for standard care.
 
 
 
CDC 1
The CDC's 2023 recommendation highlights Video Directly Observed Therapy as an equivalent alternative during TB treatment, offering significant time and cost savings.
 

 

NIH 2
VDOT for tuberculosis treatment is more cost-effective than traditional DOT, reducing both patient and health department costs, especially in high TB areas.
 

Our Partners

Partners Logo-1

Looking for a more effective TB treatment management solution? 

Join global leaders and forward-thinking organizations using SureAdhere's virtual care platform as their preferred digital adherence solution. For a demo, or to speak to our partnerships team, complete the form below.